The National Institute of Pharmaceutical Education and Research (NIPER) in Raebareli has signed a Memorandum of Understanding (MoU) with Lofty Laboratories to collaborate on pharmaceutical research and technology commercialization. The agreement aims to foster innovation in drug development and enhance industry-academia partnerships.
Scope of Collaboration
Under the MoU, both entities will work together on research projects focusing on novel drug delivery systems, analytical method development, and formulation science. The partnership also includes training programs for students and faculty, as well as joint workshops and seminars to bridge the gap between academic research and industrial applications.
Key Objectives
- Advance research in pharmaceutical sciences and technology
- Promote commercialization of research outcomes
- Provide hands-on training for students to meet industry standards
- Facilitate exchange of knowledge and resources
Lofty Laboratories, known for its expertise in pharmaceutical manufacturing and quality control, will provide industry insights and infrastructure support. NIPER Raebareli will contribute its academic expertise and research facilities. This collaboration is expected to accelerate the development of affordable medicines and innovative therapeutic solutions.
The MoU was signed in the presence of senior officials from both organizations. Dr. Anil Kumar, Director of NIPER Raebareli, emphasized that the partnership aligns with the institute's mission to produce globally competent pharmacists and researchers. A representative from Lofty Laboratories highlighted the importance of such collaborations in driving India's self-reliance in the pharmaceutical sector.
This initiative is part of a broader trend of academic-industry partnerships in India, aimed at translating research into marketable products and strengthening the country's position as a global pharmaceutical hub.
